AAAAAA
Results: 1-25/41
Authors:
Sands, BE
Tremaine, WJ
Sandborn, WJ
Rutgeerts, PJ
Hanauer, SB
Mayer, L
Targan, SR
Podolsky, DK
Citation: Be. Sands et al., Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study, INFLAMM B D, 7(2), 2001, pp. 83-88
Authors:
Chong, RY
Hanauer, SB
Cohen, RD
Citation: Ry. Chong et al., Efficacy of parenteral methotrexate in refractory Crohn's disease, ALIM PHARM, 15(1), 2001, pp. 35-44
Authors:
Hanauer, SB
Dassopoulos, T
Citation: Sb. Hanauer et T. Dassopoulos, Evolving treatment strategies for inflammatory bowel disease, ANN R MED, 52, 2001, pp. 299-318
Authors:
Ogura, Y
Bonen, DK
Inohara, N
Nicolae, DL
Chen, FF
Ramos, R
Britton, H
Moran, T
Karaliuskas, R
Duerr, RH
Achkar, JP
Brant, SR
Bayless, TM
Kirschner, BS
Hanauer, SB
Nunez, G
Cho, JH
Citation: Y. Ogura et al., A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, NATURE, 411(6837), 2001, pp. 603-606
Authors:
Sandborn, WJ
Hanauer, SB
Katz, S
Safdi, M
Wolf, DG
Baerg, RD
Tremaine, WJ
Johnson, T
Diehl, NN
Zinsmeister, AR
Citation: Wj. Sandborn et al., Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial, GASTROENTY, 121(5), 2001, pp. 1088-1094
Authors:
Sandborn, WJ
Feagan, BG
Hanauer, SB
Present, DH
Sutherland, LR
Kamm, MA
Wolf, DC
Baker, JP
Hawkey, C
Archambault, A
Bernstein, CN
Novak, C
Heath, PK
Targan, SR
Citation: Wj. Sandborn et al., An engineered human antibody to TNF (CDP571) for active Crohn's disease: Arandomized double-blind placebo-controlled trial, GASTROENTY, 120(6), 2001, pp. 1330-1338
Authors:
Hanauer, SB
Sandborn, W
Citation: Sb. Hanauer et W. Sandborn, Management of Crohn's disease in adults, AM J GASTRO, 96(3), 2001, pp. 635-643
Authors:
Kane, SV
Cohen, RD
Aikens, JE
Hanauer, SB
Citation: Sv. Kane et al., Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis, AM J GASTRO, 96(10), 2001, pp. 2929-2933
Authors:
Hanauer, SB
Citation: Sb. Hanauer, Crohn's disease therapy : step up or top down therapy, ACT GASTR B, 64(2), 2001, pp. 189-190
Authors:
Hanauer, SB
Citation: Sb. Hanauer, Biologics in peri-operative management of Crohn's disease, ACT GASTR B, 64(2), 2001, pp. 191-192
Authors:
Gasche, C
Scholmerich, J
Brynskov, J
D'Haens, G
Hanauer, SB
Irvine, EJ
Jewell, DP
Rachmilewitz, D
Sachar, DB
Sandborn, WJ
Sutherland, LR
Citation: C. Gasche et al., A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998, INFLAMM B D, 6(1), 2000, pp. 8-15
Authors:
Cho, JH
Nicolae, DL
Ramos, R
Fields, CT
Rabenau, K
Corradino, S
Brant, SR
Espinosa, R
LeBeau, M
Hanauer, SB
Bodzin, J
Bonen, DK
Citation: Jh. Cho et al., Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease, HUM MOL GEN, 9(9), 2000, pp. 1425-1432
Authors:
Rubin, DT
Hanauer, SB
Citation: Dt. Rubin et Sb. Hanauer, Smoking and inflammatory bowel disease, EUR J GASTR, 12(8), 2000, pp. 855-862
Authors:
Hanauer, SB
Citation: Sb. Hanauer, Medical therapy for ulcerative colitis, CURR OPIN G, 16(4), 2000, pp. 324-328
Authors:
Stein, RB
Hanauer, SB
Citation: Rb. Stein et Sb. Hanauer, Comparative tolerability of treatments for inflammatory bowel disease, DRUG SAFETY, 23(5), 2000, pp. 429-448
Authors:
Feagan, BG
Fedorak, RN
Irvine, EJ
Wild, G
Sutherland, L
Steinhart, AH
Greenberg, GR
Koval, J
Wong, CJ
Hopkins, M
Hanauer, SB
McDonald, JWD
Citation: Bg. Feagan et al., A comparison of methotrexate with placebo for the maintenance of remissionin Crohn's disease, N ENG J MED, 342(22), 2000, pp. 1627-1632
Authors:
Hanauer, SB
Citation: Sb. Hanauer, Surveying surveillance: Are gastroenterologists consistently inconsistent,inconsistently consistent, or poorly educated?, GASTROIN EN, 51(2), 2000, pp. 240-242
Authors:
Schreiber, S
Fedorak, RN
Nielsen, OH
Wild, G
Williams, CN
Nikolaus, S
Jacyna, M
Lashner, BA
Gangl, A
Rutgeerts, P
Isaacs, K
Van Deventer, SJH
Koningsberger, JC
Cohard, M
LeBeaut, A
Hanauer, SB
Citation: S. Schreiber et al., Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease, GASTROENTY, 119(6), 2000, pp. 1461-1472
Authors:
Fedorak, RN
Gangl, A
Elson, CO
Rutgeerts, P
Schreiber, S
Wild, G
Hanauer, SB
Kilian, A
Cohard, M
LeBeaut, A
Feagan, B
Citation: Rn. Fedorak et al., Recombinant human interleukin 10 in the treatment of patients with mild tomoderately active Crohn's disease, GASTROENTY, 119(6), 2000, pp. 1473-1482
Authors:
Brant, SR
Panhuysen, CIM
Bailey-Wilson, JE
Rohal, PM
Lee, S
Mann, J
Ravenhill, G
Kirschner, BS
Hanauer, SB
Cho, JH
Bayless, TM
Citation: Sr. Brant et al., Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity, GASTROENTY, 119(6), 2000, pp. 1483-1490
Authors:
Michelassi, F
Hurst, RD
Melis, M
Rubin, M
Cohen, R
Gasparitis, A
Hanauer, SB
Hart, J
Citation: F. Michelassi et al., Side-to-side isoperistaltic strictureplasty in extensive Crohn's disease -A prospective longitudinal study, ANN SURG, 232(3), 2000, pp. 401-406
Authors:
Achkar, JP
Hanauer, SB
Citation: Jp. Achkar et Sb. Hanauer, Medical therapy to reduce postoperative Crohn's disease recurrence, AM J GASTRO, 95(5), 2000, pp. 1139-1146
Authors:
Cohen, RD
Woseth, DM
Thisted, RA
Hanauer, SB
Citation: Rd. Cohen et al., A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis, AM J GASTRO, 95(5), 2000, pp. 1263-1276
Authors:
Cohen, RD
Tsang, JF
Hanauer, SB
Citation: Rd. Cohen et al., Infliximab in Crohn's disease: First anniversary clinical experience, AM J GASTRO, 95(12), 2000, pp. 3469-3477
Authors:
Te, HS
Schiano, TD
Kuan, SF
Hanauer, SB
Conjeevaram, HS
Baker, AL
Citation: Hs. Te et al., Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease, AM J GASTRO, 95(11), 2000, pp. 3150-3156